SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-13-005974
Filing Date
2013-11-04
Accepted
2013-11-04 16:37:41
Documents
14
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sbfm_10q.htm 10-Q 383967
2 CERTIFICATION sbfm_ex311.htm EX-31.1 16478
3 CERTIFICATION sbfm_ex312.htm EX-31.2 16128
4 CERTIFCATION sbfm_ex32.htm EX-32 10925
5 img001.jpg GRAPHIC 16911
6 img002.jpg GRAPHIC 21080
7 img003.jpg GRAPHIC 14196
8 img004.jpg GRAPHIC 10993
  Complete submission text file 0001354488-13-005974.txt   1185441

Data Files

Seq Description Document Type Size
9 sbfm-20130930.xml EX-101.INS 37045
10 sbfm-20130930.xsd EX-101.SCH 9424
11 sbfm-20130930_cal.xml EX-101.CAL 22299
12 sbfm-20130930_def.xml EX-101.DEF 10039
13 sbfm-20130930_lab.xml EX-101.LAB 75951
14 sbfm-20130930_pre.xml EX-101.PRE 55289
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 131189582
SIC: 8742 Services-Management Consulting Services